Menoufia University is one of the regional universities in Egypt, established in 1976. The university is characterized by rapid establishment and wide fame.

During the past decade, Menoufia University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Menoufia University" are "Apical Prolapse" (1 trials) and "Regional Anesthesia Morbidity" (1 trials). Many other conditions were trialed in "Menoufia University" in a lesser frequency.

Most popular intervention types in "Menoufia University" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine Injectable Solution [Dexdomitor]" (1 trials), "Lidocaine IV" (1 trials) and "patients with apical prolapse who will do Sacro hysteropexy using mersilene tape" (1 trials). Other intervention names were less common.

The vast majority of trials in "Menoufia University" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Menoufia University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Menoufia University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Menoufia University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".